ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data 5/24/2024
Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss 5/24/2024
Takeda Joins Hot Molecular Glue Market With $1.2B Deal 5/23/2024
Pfizer Targets Another $1.5B in Cost Cuts By End of 2027 5/23/2024
Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche 5/23/2024
Orna Buys Competing RNA Biotech ReNAgade After Series A Financing 5/23/2024
FDA Flags Hypoglycemia Risk for Novo’s Once-Weekly Insulin Ahead of Adcomm 5/23/2024
Appeals Court Sides With Drugmakers in 340B Case, Allows Limits on Discounts Under Program 5/23/2024
Moderna Among Companies Partnering With OpenAI to Boost AI Efforts 5/23/2024
BioSpace x DIA: Navigating the Emergence of CGT Combination Products 5/23/2024
Do You Need to Love Your Job to Be Happy at Your Job? 5/23/2024
AstraZeneca Sets $80B Revenue Target, Goal of 20 New Drugs by 2030 5/21/2024
FDA Greenlights Two Interchangeable Biosimilars to Regeneron’s Eylea 5/21/2024
Lilly Inks Potential $1.1B Radiopharma Deal with Aktis Oncology 5/21/2024
Sanofi, Regeneron Post Strong Phase III COPD Data for Dupixent as FDA Decision Looms 5/21/2024
GSK’s Long-Acting Asthma Drug Hits Primary Endpoint in Phase III Trials 5/21/2024
AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate 5/21/2024
BIO Axes 30 Staff in Realignment as Congress Advances BIOSECURE Act 5/21/2024
Amgen Wins FDA Approval for Difficult-to-Treat Lung Cancer 5/17/2024
GSK to Sell Remaining Stake in Haleon, Looks to Raise $1.52B 5/17/2024